921
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Risk factors for short-term re-bleeding in patients with colonic diverticular bleeding: a multicenter retrospective study

ORCID Icon, ORCID Icon, , , , , , , , , , , & show all
Received 11 Dec 2021, Accepted 24 Jan 2022, Published online: 09 Feb 2022

References

  • Yamamichi N, Shimamoto T, Takahashi Y, et al. Trend and risk factors of diverticulosis in Japan: age, gender, and lifestyle/metabolic-related factors may cooperatively affect on the colorectal diverticula formation. PLoS One. 2015;10(4):e0123688.
  • Nagata N, Niikura R, Aoki T, et al. Increase in colonic diverticulosis and diverticular hemorrhage in an aging society: lessons from a 9-year colonoscopic study of 28192 patients in Japan. Int J Colorectal Dis. 2014;29:379–385.
  • Gralnek IM, Neeman Z, Strate LL. Acute lower gastrointestinal bleeding. N Engl J Med. 2017;376(11):1054–1063.
  • Aoki T, Nagata N, Shimbo T, et al. Development and validation of a risk scoring system for severe acute lower gastrointestinal bleeding. Clin Gastroenterol Hepatol. 2016;14(11):1562–1570.
  • Xavier SA, Machado FJ, Magalhaes JT, et al. Acute lower gastrointestinal bleeding: are STRATE and BLEED scores valid in clinical practice? Colorectal Dis. 2019;21:357–364.
  • Strate LL, Liu YL, Huang ES, et al. Use of aspirin or nonsteroidal anti-inflammatory drugs increases risk for diverticulitis and diverticular bleeding. Gastroenterology. 2011;140(5):1427–1433.
  • Yamada A, Sugimoto T, Kondo S, et al. Assessment of the risk factors for colonic diverticular hemorrhage. Dis Colon Rectum. 2008;51(1):116–120.
  • Taki M, Oshima T, Tozawa K, et al. Analysis of risk factors for colonic diverticular bleeding and recurrence. Medicine (Baltimore). 2017;96(38):e8090.
  • Yuhara H, Corley DA, Nakahara F, et al. Aspirin and non-aspirin NSAIDs increase risk of colonic diverticular bleeding: a systematic review and Meta-analysis. J Gastroenterol. 2014;49(6):992–1000.
  • Nagata N, Niikura R, Aoki T, et al. Colonic diverticular hemorrhage associated with the use of nonsteroidal anti-inflammatory drugs, low-dose aspirin, antiplatelet drugs, and dual therapy. J Gastroenterol Hepatol. 2014;29:1786–1793.
  • Joaquim N, Caldeira P, Antunes AG, et al. Risk factor of severity and recurrence of colonic diverticular bleeding. Rev Esp Enferm Dig. 2017;109(1):3–9.
  • Nagata N, Niikura R, Aoki T, et al. Risk factors for adverse in-hospital outcomes in acute colonic diverticular hemorrhage. World J Gastroenterol. 2015;21(37):10697–10703.
  • Gonai T, Toya Y, Kawasaki K, et al. Clinical impact of antithrombotic therapy on colonic diverticular bleeding. DEN Open. 2022;2(1):e22.
  • Vajravelu RK, Mamtani R, Scott FI, et al. Incidence, risk factors, and clinical effects of recurrent diverticular hemorrhage: a large cohort study. Gastroenterology. 2018;155(5):1416–1427.
  • Niikura R, Nagata N, Yamada A, et al. Recurrence of colonic diverticular bleeding and associated risk factors. Colorectal Dis. 2012;14(3):302–305.
  • Nishikawa H, Maruo T, Tsumura T, et al. Risk factors associated with recurrent hemorrhage after the initial improvement of colonic diverticular bleeding. Acta Gastroenterol Belg. 2013;76:20–24.
  • Chan FK, Leung Ki EL, Wong GL, et al. Risk of bleeding recurrence and cardiovascular events with continued aspirin use after lower gastrointestinal hemorrhage. Gastroenterology. 2016;151(2):271–277.
  • Sengupta N, Feuerstein JD, Patwardhan VR, et al. The risks of thromboembolism vs. recurrent gastrointestinal bleeding after interruption of systemic anticoagulation in hospitalized inpatients with gastrointestinal bleeding: a prospective study. Am J Gastroenterol. 2015;110(2):328–335.
  • Chai-Adisaksopha C, Hillis C, Monreal M, et al. Thromboembolic events, recurrent bleeding and mortality after resuming anticoagulant following gastrointestinal bleeding. A Meta-analysis. Thromb Haemost. 2015;114(10):819–825.
  • Nagata N, Sakurai T, Shimbo T, et al. Acute severe gastrointestinal tract bleeding is associated with an increased risk of thromboembolism and death. Clin Gastroenterol Hepatol. 2017;15(12):1882–1889.
  • Fujino Y, Inoue Y, Onodera M, et al. Risk factors for early re-bleeding and associated hospitalization in patients with colonic diverticular bleeding. Colorectal Dis. 2013;15(8):982–986.
  • Kitagawa T, Katayama Y, Kobori I, et al. Predictors of 90-day colonic diverticular recurrent bleeding and readmission. Intern Med. 2019;58(16):2277–2282.
  • Nagata N, Ishii N, Manabe N, et al. Guidelines for colonic diverticular bleeding and colonic diverticulitis: Japan gastroenterological association. Digestion. 2019;99(Suppl. 1):1–26.
  • Fujimoto K, Fujishiro M, Kato M, et al. Guidelines for gastroenterological endoscopy in patients undergoing antithrombotic treatment. Dig Endosc. 2014;26(1):1–14.
  • Nigam N, Ham SA, Sengupta N. Early colonoscopy for diverticular bleeding does not reduce risk of postdischarge recurrent bleeding: a propensity score matching analysis. Clin Gastroenterol Hepatol. 2019;17(6):1105–1111.
  • Strate LL, Gralnek IM. ACG clinical guideline: management of patients with acute lower gastrointestinal bleeding. Am J Gastroenterol. 2016;111(4):459–474.
  • Oakland K, Chadwick G, East JE, et al. Diagnosis and management of acute lower gastrointestinal bleeding: guidelines from the British Society of Gastroenterology. Gut. 2019;68(5):776–789.
  • Maulaz AB, Bezerra DC, Michel P, et al. Effect of discontinuing aspirin therapy on the risk of brain ischemic stroke. Arch Neurol. 2005;62(8):1217–1220.
  • Vene N, Mavri A, Gubensek M, et al. Risk of thromboembolic events in patients with non-valvular atrial fibrillation after dabigatran or rivaroxaban discontinuation – data from the ljubljana registry. PLoS One. 2016;11(6):e0156943.
  • Raunso J, Selmer C, Olesen JB, et al. Increased short-term risk of thrombo-embolism or death after interruption of warfarin treatment in patients with atrial fibrillation. Eur Heart J. 2012;33(15):1886–1892.
  • Qureshi W, Mittal C, Patsias I, et al. Restarting anticoagulation and outcomes after major gastrointestinal bleeding in atrial fibrillation. Am J Cardiol. 2014;113(4):662–668.
  • Nagata N, Sakurai T, Moriyasu S, et al. Impact of INR monitoring, reversal agent use, heparin bridging, and anticoagulant interruption on rebleeding and thromboembolism in acute gastrointestinal bleeding. PLoS One. 2017;12(9):e0183423.
  • Oakland K, Guy R, Uberoi R, et al. Acute lower GI bleeding in the UK: patients characteristics, interventions and outcomes in the first nationwide audit. Gut. 2018;67:654–662.
  • Oakland K, Desborough MJ, Murphy MF, et al. Rebleeding and mortality after lower gastrointestinal Bleeding in Patients Taking Antiplatelets or Anticoagulants. Clin Gastroenterol Hepatol. 2019;17(7):1276–1284.
  • Patel P, Nigam N, Sengupta N. Lower gastrointestinal bleeding in patients with coronary artery disease on antithrombotics and subsequent mortality risk. J Gastroenterol Hepatol. 2018;33(6):1185–1191.
  • Sorensen R, Hansen ML, Abildstrom SZ, et al. Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data. Lancet. 2009;374(9706):1967–1974.
  • Yasuda S, Kaikita K, Akao M, et al. Antithrombotic therapy for atrial fibrillation with stable coronary disease. N Engl J Med. 2019;381(12):1103–1113.
  • Okamoto N, Tominaga N, Sakata Y, et al. Low rebleeding rate after endoscopic band ligation than endoscopic clipping of the same colonic diverticular hemorrhagic lesion: a historical multicenter trial in Saga, Japan. Intern Med. 2019;58(5):633–638.
  • Tsuruoka N, Iwakiri R, Hara M, et al. NSAIDs are a significant risk factor for colonic diverticular hemorrhage in elder patients: evaluation by a case-control study. J Gastroenterol Hepatol. 2011;26(6):1047–1052.